New drug for schizophrenics has experts excited

By Agence France-Presse

Sep 28, 2024 6:04 pm

WASHINGTON, D.C. — Experts expressed enthusiasm Friday after US health regulators approved the first new form of treatment for schizophrenia in decades.

The drug, called Cobenfy and developed by US pharma giant Bristol Myers Squibb, works differently from existing treatments, targeting the so-called cholinergic receptors, not the dopamine receptors.

Already have an active account? Log in here to continue reading.
Or
Subscribe to the Premium Subscription plan to access this subscriber-exclusive article.

Related Articles

Strong winds threaten LA's battle vs wildfires

Gaza truce talks enter 'final round' in Qatar

'Trump would've been convicted if he wasn't elected'

US stronger on global stage in decades – Biden

Russian, Iranian leaders to ink partnership pact

Pope Francis is introspective and self-critical in his autobiography, at least about his youth

Prosecutor who investigated Hunter Biden defends probes, denounces president's remarks in new report